Jackie R Glenn
Overview
Explore the profile of Jackie R Glenn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kilpatrick L, Alcobia D, White C, Peach C, Glenn J, Zimmerman K, et al.
Cell Chem Biol
. 2019 Apr;
26(6):830-841.e9.
PMID: 30956148
Vascular endothelial growth factor (VEGF) is an important mediator of endothelial cell proliferation and angiogenesis via its receptor VEGFR2. A common tumor associated with elevated VEGFR2 signaling is infantile hemangioma...
2.
Fox S, May J, Dovlatova N, Glenn J, Johnson A, White A, et al.
Platelets
. 2018 Feb;
30(3):290-295.
PMID: 29461906
Measurement of P-selectin on activated platelets as a means of measuring platelet function utilizing the technology described here has the advantage of not requiring immediate access to specialist equipment and...
3.
Iyu D, Glenn J, White A, Fox S, Dovlatova N, Heptinstall S
Platelets
. 2011 May;
22(7):504-15.
PMID: 21591981
Several antiplatelet drugs that are used or in development as antithrombotic agents, such as antagonists of P2Y₁₂ and EP3 receptors, act as antagonists at G(i)-coupled receptors, thus preventing a reduction...
4.
Iyu D, Glenn J, White A, Fox S, Heptinstall S
Arterioscler Thromb Vasc Biol
. 2010 Nov;
31(2):416-22.
PMID: 21106949
Objective: To investigate whether adenosine diphosphate (ADP)-derived adenosine might inhibit platelet aggregation, especially in the presence of a P2Y₁₂ antagonist, where the effects of ADP at the P2Y₁₂ receptor would...
5.
Iyu D, Juttner M, Glenn J, White A, Johnson A, Fox S, et al.
Prostaglandins Other Lipid Mediat
. 2010 Nov;
94(1-2):9-16.
PMID: 21095237
There is evidence that the overall effects of prostaglandin E(2) (PGE(2)) on human platelet function are the consequence of a balance between promotory effects of PGE(2) acting at the EP3...
6.
Iyu D, Glenn J, White A, Fox S, van Giezen H, Nylander S, et al.
Thromb Haemost
. 2010 Oct;
105(1):96-106.
PMID: 20941457
P2Y(12) receptor antagonists are antithrombotic agents that inhibit platelet function by blocking the effects of adenosine diphosphate (ADP) at P2Y (12)receptors. However, some P2Y(12) receptor antagonists may affect platelet function...
7.
Iyu D, Glenn J, White A, Johnson A, Fox S, Heptinstall S
Platelets
. 2010 May;
21(5):329-42.
PMID: 20433310
The effects of prostaglandin E(2) (PGE(2)) on platelet function are believed to be the result of opposing mechanisms that lead to both enhancement and inhibition of platelet function. Enhancement of...
8.
Heptinstall S, Espinosa D, Manolopoulos P, Glenn J, White A, Johnson A, et al.
Platelets
. 2008 Nov;
19(8):605-13.
PMID: 19012178
Receptors for prostanoids on platelets include the EP3 receptor for which the natural agonist is the inflammatory mediator prostaglandin E(2) (PGE(2)) produced in atherosclerotic plaques. EP3 is implicated in atherothrombosis...
9.
Heptinstall S, Glenn J, May J, Storey R, Wilcox R
Catheter Cardiovasc Interv
. 2004 Oct;
63(3):397-8.
PMID: 15505861
No abstract available.